Impaired osteoblast and osteoclast function characterize the osteoporosis of Snyder - Robinson syndrome-Reference-Cited by-同舟云学术

Impaired osteoblast and osteoclast function characterize the osteoporosis of Snyder - Robinson syndrome

Published:2015-03-07 Issue:1 Volume:10 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Albert Jessica S,Bhattacharyya Nisan,Wolfe Lynne A,Bone William P,Maduro Valerie,Accardi John,Adams David R,Schwartz Charles E,Norris Joy,Wood Tim,Gafni Rachel I,Collins Michael T,Tosi Laura L,Markello Thomas C,Gahl William A,Boerkoel Cornelius F

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-015-0235-8.pdf

Reference57 articles.

1. D'Agostino L, Di Luccia A. Polyamines interact with DNA as molecular aggregates. Eur J Biochem. 2002;269(17):4317–25.

2. Watanabe S, Ksama-Equchi K, Kobayashi H, Igarashi K. Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem. 1991;266(31):20803–9.

3. Minois N, Carmona-Gutierrez D, Madeo F. Polyamines in aging and disease. Aging. 2011;3(8):716–32.

4. Raina A, Janne J. Physiology of the natural polyamines putrescine, spermidine and spermine. Med Biol. 1975;53(3):121–47.

5. Pegg AE, Michael AJ. Spermine synthase. Cell Mol Life Sci. 2010;67(1):113–21.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro and in vivo studies on exogenous polyamines and α-difluoromethylornithine to enhance bone formation and suppress osteoclast differentiation;Amino Acids;2024-06-27

2. Structural Insights into the Mechanisms Underlying Polyaminopathies;International Journal of Molecular Sciences;2024-06-07

3. Effects of Spermine Synthase Deficiency in Mesenchymal Stromal Cells Are Rescued by Upstream Inhibition of Ornithine Decarboxylase;International Journal of Molecular Sciences;2024-02-20

4. Bone manifestations in Snyder‐Robinson syndrome;Rare;2024

5. Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome;EMBO Molecular Medicine;2023-09-13